Apimeds Pharmaceuticals US, Inc. (APUS)

NYSEAMERICAN: APUS · Real-Time Price · USD

2.300

-0.120 (-4.96%)

Sep 8, 2026, 4:00 PM EDT - Market closed

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.06	-0.50	8.38	-0.96	-1.68
Quick Ratio	6.41	0.00	3.33	0.02	16.09
Current Ratio	8.34	0.01	3.42	0.02	16.16
Return on Assets (ROA)	-69.29%	-366.30%	-218.17%	-448.25%	-
Return on Invested Capital (ROIC)	-78.61%	-	-348.55%	-611.12%	-
Return on Capital Employed (ROCE)	-63.10%	126.10%	-250.20%	203.90%	-631.20%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-29.09%	-71.89%	-19.55%	-	-

SEC Filings: 10-K · 10-Q